🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
REG
$REGN
🔒 US EquitiesRegeneron Pharmaceuticals, Inc.
AVG HISTORICAL GAP
-0.28%
MAX GAP RECORD
-6.04%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $REGN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$REGN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 30, 2026 Earnings Release 2026-10-30 (BEFORE OPEN (08:00)) | 🔮 UPCOMING 🔒 |
| Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN) |
-1.49%
|
| Apr 29, 2026 Earnings Release 2026-04-29 (AFTER CLOSE) |
-1.45%
|
| Jan 30, 2026 Earnings Release 2026-01-30 (AFTER CLOSE) |
-1.15%
|
| Oct 28, 2025 Earnings Release 2025-10-28 (BEFORE OPEN) |
+4.56%
|
| Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN) |
+0.27%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-2.49%
|
| Feb 05, 2025 Earnings Release 2025-02-05 (BEFORE OPEN) |
+1.69%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.1%
Bullish Gaps (6)
Bearish Gaps (7)
Neutral / Flat (2)
📖 Intelligence Summary
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗